Improvement of brain function in hemodialysis patients treated with erythropoietin
Authors:
- Felix StockenhuberFSFelix Stockenhuber
- Bruno SchneeweissBSBruno Schneeweiss
- Christian MadlCMChristian Madl
- Josef ZeitlhoferJZJosef Zeitlhofer
- Barbara SchneiderBSBarbara Schneider
- 1 September 1990
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 38 (3) , 480-486
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Anaemia and reduced exercise capacity in patients on chronic haemodialysisClinical Science, 1989
- Working capacity is increased following recombinant human erythropoietin treatmentKidney International, 1988
- BLOOD PRESSURE AND ERYTHROPOIETINThe Lancet, 1988
- HYPERTENSION, BLOOD VISCOSITY, AND CARDIOVASCULAR MORBIDITY IN RENAL FAILURE: IMPLICATIONS OF ERYTHROPOIETIN THERAPYThe Lancet, 1988
- Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis.BMJ, 1987
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986
- The Quality of Life of Patients with End-Stage Renal DiseaseNew England Journal of Medicine, 1985
- Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiencyKidney International, 1984
- Visual evoked potentials and long latency event‐related potentials in chronic renal failureNeurology, 1983